{"name": "Wilmington Pharmaceuticals",
 "permalink": "wilmington-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/wilmington-pharmaceuticals",
 "homepage_url": "http://www.wilmingtonpharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@wilmingtonpharma.com",
 "phone_number": "910-509-0097",
 "description": "",
 "created_at": "Fri Apr 30 08:59:47 UTC 2010",
 "updated_at": "Fri Apr 30 09:07:27 UTC 2010",
 "overview": "\u003Cp\u003EAt Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0008/5457/85457v1-max-150x150.jpg"],
     [[250,
       59],
      "assets/images/resized/0008/5457/85457v1-max-250x250.jpg"],
     [[333,
       79],
      "assets/images/resized/0008/5457/85457v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.3M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 1300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 10,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Wilmington Investor Network",
         "permalink": "wilmington-investor-network",
         "image":
          {"available_sizes":
            [[[127,
               115],
              "assets/images/resized/0004/6799/46799v1-max-150x150.jpg"],
             [[127,
               115],
              "assets/images/resized/0004/6799/46799v1-max-250x250.jpg"],
             [[127,
               115],
              "assets/images/resized/0004/6799/46799v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Emergent Growth Fund",
         "permalink": "emergent-growth-fund",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0008/5459/85459v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0008/5459/85459v1-max-250x250.jpg"],
             [[418,
               58],
              "assets/images/resized/0008/5459/85459v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1904 Eastwood Road",
    "address2": "Suite 305",
    "zip_code": "28403",
    "city": "Wilmington",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        102],
       "assets/images/resized/0008/5458/85458v1-max-150x150.jpg"],
      [[250,
        171],
       "assets/images/resized/0008/5458/85458v1-max-250x250.jpg"],
      [[450,
        307],
       "assets/images/resized/0008/5458/85458v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}